RRM2 and cancer: These complex regulation mechanisms mediated by cyclin F could be significant to the cancer field, since aberrant expression of RRM2 has been found in multiple types of cancers and failure to maintain the balance of dNTP can cause genome instability (Xu et al, 2008; Kumar et al, 2011; Ahluwalia & Schaaper, 2013).